Rasmussen, Eva Sara
560  Ergebnisse:
Personensuche X
?
1

Teknologier til kystsikring i dansk kontekst:PIXI-rapport:

Faragò, Maria ; Rasmussen, Eva Sara ; Fryd, Ole...
Faragò , M , Rasmussen , E S , Fryd , O , Nielsen , E R , Kleffel , K V & Arnbjerg-Nielsen , K 2019 , Teknologier til kystsikring i dansk kontekst : PIXI-rapport . Vand i Byer ..  , 2019
 
?
2

Coastal protection technologies in a Danish context:

Faragò, Maria ; Rasmussen, Eva Sara ; Fryd, Ole..
Faragò , M , Rasmussen , E S , Fryd , O , Rønde Nielsen , E & Arnbjerg-Nielsen , K 2018 , Coastal protection technologies in a Danish context . Vand i Byer ..  , 2018
 
?
5

The effectiveness of natalizumab vs fingolimod–A comparison..:

Andersen, Johanna B ; Sharmin, Sifat ; Lefort, Mathilde...
Multiple Sclerosis and Related Disorders.  53 (2021)  - p. 103012 , 2021
 
?
11

Impact of methodological choices in comparative effectivene..:

Lefort, Mathilde ; Sharmin, Sifat ; Andersen, Johanna Balslev...
BMC Medical Research Methodology. -22 : 1 (2022), p. 1-14. -BMC Med. Res. Methodol. - 1471-2288.  , 2022
 
?
13

The effectiveness of natalizumab vs fingolimod: a compariso..:

Andersen, Johanna Balslev ; Sharmin, Sifat ; Lefort, Mathilde...
Multiple Sclerosis and Related Disorders. -53 (2021), p. 1-15. -Mult. Scler. Relat. Disord. - 2211-0348.  , 2021
 
?
14

The effectiveness of natalizumab vs fingolimod–A comparison..:

Andersen, Johanna B ; Sharmin, Sifat ; Lefort, Mathilde...
https://vbn.aau.dk/da/publications/55948327-b643-46df-8de8-ca4ad65ba6ea.  , 2021
 
?
15

The effectiveness of natalizumab vs fingolimod–A comparison..:

Andersen, Johanna B ; Sharmin, Sifat ; Lefort, Mathilde...
https://pure.au.dk/portal/da/publications/the-effectiveness-of-natalizumab-vs-fingolimoda-comparison-of-international-registry-studies(4f8541fc-589c-4bbe-ae69-7cec42396a76).html.  , 2021
 
1-15
Mehr Literatur finden